Research Article

Cyclooxygenase-2 Expression Is a Predictive Marker for Late Recurrence in Colorectal Cancer

Table 3

Univariate and multivariate analysis of independent risk factors associated with late recurrence.

VariableEarly recurrence (<3 yr) ()Late recurrence (≥3 yr) ()Univariate analysis ( value)Multivariate analysis (OR, 95% CI, value)

Age (yr)0.382
 <7056 (78.9%)24 (88.9%)
 ≥7015 (21.1%)3 (11.1%)0.726 (0.174–3.024) 0.660
Gender0.473
 Male39 (54.9%)17 (63.0%)0.996 (0.361–2.747) 0.993
 Female32 (45.1%)10 (37.0%)
Tumor location1.000
 Right colon18 (25.3%)7 (25.9%)
 Left colon12 (16.9%)4 (14.8%)
 Rectum41 (57.7%)16 (59.3%)
Tumor size0.965
 <5 cm24 (33.8%)9 (33.3%)
 ≥5 cm47 (66.2%)18 (66.7%)
Gross type0.280
 Fungating30 (42.3%)14 (51.9%)
 Infiltrative36 (50.7%)10 (37.0%)
 Unknown5 (7.0%)3 (11.1%)
Cell type0.614
 Nonmucinous68 (95.8%)25 (92.6%)
 Mucinous3 (4.2%)2 (7.4%)
Differentiation0.818
 WD3 (4.2%)1 (3.7%)
 MD53 (74.6%)22 (81.5%)
 PD15 (21.1%)4 (14.8%)
Lymphatic invasion0.012
 Absent10 (14.1%)10 (37.0%)
 Present61 (85.9%)17 (63.0%)0.309 (0.103–0.924) 0.036
Vascular invasion1.000
 Absent71 (100%)27 (100%)
 Present0 (0%)0 (0%)
T category0.193
 T10 (0%)0 (0%)
 T21 (1.4%)2 (7.4%)
 T367 (94.4%)25 (92.6%)
 T43 (4.2%)0 (0%)
N category0.102
 N012 (16.9%)10 (37.0%)
 N121 (29.6%)6 (22.3%)
 N238 (53.5%)11 (40.7%)
Stage0.051
 I0 (0%)1 (3.7%)
 II13 (18.3%)9 (33.3%)
 III58 (81.7%)17 (63.0%)1.315 (0.256–6.753) 0.743
COX-2 expression0.001
 Negative45 (63.4%)7 (25.9%)
 Positive26 (36.6%)20 (74.1%)4.656 (1.696–12.779) 0.003